Verteporfin attenuates NLRP3 inflammasome activation to alleviate gout arthritis flares

Collectively, these data suggest verteporfin is a NLRP3 inflammasome inhibitor that could be repurposed as a treatment for GA.

Authors

Institutions

Publication Details

Journal
Journal of Inflammation
Published
2025-07-16
DOI
https://doi.org/10.1186/s12950-025-00455-9
Citations
1
Primary Topic
Inflammasome and immune disorders
Type
article
Field-Weighted Citation Impact
0.81

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Verteporfin attenuates NLRP3 inflammasome activation to alleviate gout arthritis flares

Tyler K. Ulland, Daniel C. Shippy
1 citations
Journal of Inflammation
Inflammasome and immune disorders
0.81
article

Verteporfin attenuates NLRP3 inflammasome activation to alleviate gout arthritis flares

Tyler K. Ulland, Daniel C. Shippy
article en
1 citations

Abstract

Collectively, these data suggest verteporfin is a NLRP3 inflammasome inhibitor that could be repurposed as a treatment for GA.

Journal of InflammationVol. 22(1)
University of Wisconsin–Madison (US)
William F. Vilas Trust Estate, National Institutes of Health
Zero hunger
Openalex Percentile: Top 26%
Inflammasome and immune disorders
0.81
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Verteporfin attenuates NLRP3 inflammasome activation to alleviate gout arthritis flares — Tyler K. Ulland, Daniel C. Shippy · Journal of Inflammation (2025) | TGRS Research Map | TGRS